Надана інформація про лікарські засоби призначена виключно для ознайомлення і не є офертою, рекламою чи інструкцією щодо застосування. Продаж, доставка та призначення препаратів через сайт не здійснюються. З питань застосування препарату ви можете записатися на очний прийом або онлайн-консультацію до профільного спеціаліста нашої клініки.
DAXAS (ITALY)
1 tablet contains 500 mcg of roflumilast.
128у.е.
Composition
Active ingredient: roflumilast
Pharmacotherapeutic group
Drugs used in obstructive airway diseases. Other systemic drugs for obstructive airway diseases.
Indications
For maintenance therapy of severe chronic obstructive pulmonary disease (COPD) (forced expiratory volume in one second [FEV1] after bronchodilator use less than 50% of predicted) associated with chronic bronchitis in adults and with a history of frequent COPD exacerbations, as an add-on to bronchodilator therapy.
Contraindications
Hypersensitivity to roflumilast or any other components of the medication.
Moderate or severe liver failure.
Dosage and administration
The recommended dose for adults is 1 tablet (500 mcg of roflumilast) once daily.
It may take several weeks of treatment to achieve a therapeutic effect.
Method of administration
For oral use.
The tablet should be swallowed with water. The medication should be taken daily at the same time. Tablets can be taken with or without food.
Children
Daxas is not used in children (under 18 years of age) for the indication of COPD.
Dosage form: 500 mcg tablets.
Package contains 30 tablets.
Active ingredient: roflumilast
Pharmacotherapeutic group
Drugs used in obstructive airway diseases. Other systemic drugs for obstructive airway diseases.
Indications
For maintenance therapy of severe chronic obstructive pulmonary disease (COPD) (forced expiratory volume in one second [FEV1] after bronchodilator use less than 50% of predicted) associated with chronic bronchitis in adults and with a history of frequent COPD exacerbations, as an add-on to bronchodilator therapy.
Contraindications
Hypersensitivity to roflumilast or any other components of the medication.
Moderate or severe liver failure.
Dosage and administration
The recommended dose for adults is 1 tablet (500 mcg of roflumilast) once daily.
It may take several weeks of treatment to achieve a therapeutic effect.
Method of administration
For oral use.
The tablet should be swallowed with water. The medication should be taken daily at the same time. Tablets can be taken with or without food.
Children
Daxas is not used in children (under 18 years of age) for the indication of COPD.
Dosage form: 500 mcg tablets.
Package contains 30 tablets.
